CDKN2A and melanoma: Until recently, the primary genes that were recognized and clinically evaluated for predisposition to melanoma were CDKN2A/ARF (cyclin-dependent kinase inhibitor 2A) and its associated gene CDK4 (cyclin-dependent kinase 4) [15,19].